Skip to main content

21.03.2024 | Hypertension and Obesity (E Reisin, Section Editor)

The Role of Obesity in the Development of Preeclampsia

verfasst von: Miguel Javier Schiavone, Mariana Paula Pérez, Analía Aquieri, Daniela Nosetto, María Victoria Pronotti, María Mazzei, Cyntia Kudrle, Horacio Avaca

Erschienen in: Current Hypertension Reports

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This comprehensive review provides an in-depth exploration of the complex relationship between obesity and preeclampsia (PE) and emphasizes the clinical implications of this association. It highlights the crucial role of screening tools in assessing individual risk and determining the need for additional antenatal care among women with obesity. The review investigates various markers for identifying the risk of developing PE, while emphasizing the significance of interventions such as exercise, weight management, and a balanced diet in reducing the incidence of preeclampsia and improving outcomes for both mother and fetus.

Recent Findings

Actually, there is a global pandemic of obesity, particularly among women of childbearing age and pregnant women. PE, which is characterized by maternal hypertension, proteinuria, and complications, affects 2–4% of pregnancies worldwide, posing significant risks to maternal and perinatal health. Women with obesity face an elevated risk of developing PE due to the systemic inflammation resulting from excess adiposity, which can adversely affect placental development. Adipose tissue, rich in proinflammatory cytokines and complement proteins, contributes to the pathogenesis of PE by promoting the expression of antiangiogenic factors in the mother.

Summary

This review emphasizes the need for appropriate screening, interventions, and a holistic approach to reduce the incidence of preeclampsia and enhance maternal-fetal well-being, thus providing valuable insights into the multifaceted association between obesity and PE.

Graphical Abstract

Literatur
4.
Zurück zum Zitat Purnell JQ. Definitions, classification, and epidemiology of obesity. 2018 Apr 12. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Hofland J, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP (eds.), Endotext [Internet]. South Dartmouth (MA) Inc.; 2000. MDText.com. PMID: 25905390. Purnell JQ. Definitions, classification, and epidemiology of obesity. 2018 Apr 12. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Hofland J, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP (eds.), Endotext [Internet]. South Dartmouth (MA) Inc.; 2000. MDText.​com. PMID: 25905390.
5.
Zurück zum Zitat • Poniedziałek-Czajkowska E, Mierzyński R, Leszczyńska-Gorzelak B. Preeclampsia and obesity-the preventive role of exercise. Int J Environ Res Public Health. 2023;20(2):1267. https://doi.org/10.3390/ijerph20021267. PMID: 36674022; PMCID: PMC9859423. The objective of this paper is to elucidate the mechanisms underlying the occurrence of hypertension during pregnancy among women with obesity and to emphasize the significance of exercise in its prevention.CrossRefPubMedPubMedCentral • Poniedziałek-Czajkowska E, Mierzyński R, Leszczyńska-Gorzelak B. Preeclampsia and obesity-the preventive role of exercise. Int J Environ Res Public Health. 2023;20(2):1267. https://​doi.​org/​10.​3390/​ijerph20021267. PMID: 36674022; PMCID: PMC9859423. The objective of this paper is to elucidate the mechanisms underlying the occurrence of hypertension during pregnancy among women with obesity and to emphasize the significance of exercise in its prevention.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat • Alston MC, Redman LM, Sones JL. An overview of obesity, cholesterol, and systemic inflammation in preeclampsia. Nutrients. 2022;14(10):2087. https://doi.org/10.3390/nu14102087. PMID: 35631228; PMCID: PMC9143481. This review aims to provide a summary of the current understanding regarding the involvement of nutrients, obesity, and cholesterol signaling in the development of PE.CrossRefPubMedPubMedCentral • Alston MC, Redman LM, Sones JL. An overview of obesity, cholesterol, and systemic inflammation in preeclampsia. Nutrients. 2022;14(10):2087. https://​doi.​org/​10.​3390/​nu14102087. PMID: 35631228; PMCID: PMC9143481. This review aims to provide a summary of the current understanding regarding the involvement of nutrients, obesity, and cholesterol signaling in the development of PE.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Catalano PM, Shankar K. Obesity and pregnancy: mechanisms of short term and long-term adverse consequences for mother and child. BMJ. 2017;356: j1.CrossRefPubMedPubMedCentral Catalano PM, Shankar K. Obesity and pregnancy: mechanisms of short term and long-term adverse consequences for mother and child. BMJ. 2017;356: j1.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Institute of Medicine. Committee to Reexamine IOM Pregnancy Weight Guidelines, Food and Nutrition Board and Board on Children Y, and Families: weight gain during pregnancy: reexamining the guidelines. Washington: The National Academies press; 2009. Institute of Medicine. Committee to Reexamine IOM Pregnancy Weight Guidelines, Food and Nutrition Board and Board on Children Y, and Families: weight gain during pregnancy: reexamining the guidelines. Washington: The National Academies press; 2009.
19.
Zurück zum Zitat Haugen M, Brantsæter AL, Winkvist A, Lissner L, Alexander J, Oftedal B, et al. Associations of pre-pregnancy body mass index and gestational weight gain with pregnancy outcome and postpartum weight retention: a prospective observational cohort study. BMC Pregnancy Childbirth. 2014;11(14):201. https://doi.org/10.1186/1471-2393-14-201. PMID: 24917037; PMCID: PMC4062904.CrossRef Haugen M, Brantsæter AL, Winkvist A, Lissner L, Alexander J, Oftedal B, et al. Associations of pre-pregnancy body mass index and gestational weight gain with pregnancy outcome and postpartum weight retention: a prospective observational cohort study. BMC Pregnancy Childbirth. 2014;11(14):201. https://​doi.​org/​10.​1186/​1471-2393-14-201. PMID: 24917037; PMCID: PMC4062904.CrossRef
21.
Zurück zum Zitat • Rogers BN, Stephens JM, Sones JL. Linking inflammatory adipose tissue to placental abnormalities in obese preeclamptic pregnancies. Physiol Genomics. 2022;54(8):319–24. https://doi.org/10.1152/physiolgenomics.00041.2022. Epub 2022 Jul 11. PMID: 35816649; PMCID: PMC9377783. This review encompasses the examination of inflammatory adipokines, immune cells, and compromised placental development linked toPE in both women and animal models.CrossRefPubMedPubMedCentral • Rogers BN, Stephens JM, Sones JL. Linking inflammatory adipose tissue to placental abnormalities in obese preeclamptic pregnancies. Physiol Genomics. 2022;54(8):319–24. https://​doi.​org/​10.​1152/​physiolgenomics.​00041.​2022. Epub 2022 Jul 11. PMID: 35816649; PMCID: PMC9377783. This review encompasses the examination of inflammatory adipokines, immune cells, and compromised placental development linked toPE in both women and animal models.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat • Lopez-Jaramillo P, Barajas J, Rueda-Quijano SM, Lopez-Lopez C, Felix C. Obesity and preeclampsia: common pathophysiological mechanisms. Front Physiol. 2018;19(9):1838. https://doi.org/10.3389/fphys.2018.01838. PMID: 30618843; PMCID: PMC6305943. This article discusses in detail studies conducted in various populations that highlight the connection between obesity and overweight with the occurrence of preeclampsia.CrossRef • Lopez-Jaramillo P, Barajas J, Rueda-Quijano SM, Lopez-Lopez C, Felix C. Obesity and preeclampsia: common pathophysiological mechanisms. Front Physiol. 2018;19(9):1838. https://​doi.​org/​10.​3389/​fphys.​2018.​01838. PMID: 30618843; PMCID: PMC6305943. This article discusses in detail studies conducted in various populations that highlight the connection between obesity and overweight with the occurrence of preeclampsia.CrossRef
33.
35.
Zurück zum Zitat Antonioli L, Colucci R, La Motta C, Tuccori M, Awwad O, Da Settimo F, et al. Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders. Curr Drug Targets. 2012;13(6):842–62.CrossRefPubMed Antonioli L, Colucci R, La Motta C, Tuccori M, Awwad O, Da Settimo F, et al. Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders. Curr Drug Targets. 2012;13(6):842–62.CrossRefPubMed
36.
Zurück zum Zitat Choi J, Joseph L, Pilote L. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev J Int Assoc Study Obes. 2013;14(3):232–44.CrossRef Choi J, Joseph L, Pilote L. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev J Int Assoc Study Obes. 2013;14(3):232–44.CrossRef
37.
38.
Zurück zum Zitat Zelinka-Khobzey MM, Tarasenko KV, Mamontova TV. Assessment of Endothelial Dysfunction in Pregnant Women with Obesity and Preeclampsia. Wiad Lek. 2021;74(8):1905–9. PMID: 34537741.CrossRefPubMed Zelinka-Khobzey MM, Tarasenko KV, Mamontova TV. Assessment of Endothelial Dysfunction in Pregnant Women with Obesity and Preeclampsia. Wiad Lek. 2021;74(8):1905–9. PMID: 34537741.CrossRefPubMed
39.
Zurück zum Zitat Veiga ECA, Korkes HA, Salomão KB, Cavalli RC. Association of LEPTIN and other inflammatory markers with preeclampsia: a systematic review. Front Pharmacol. 2022;10(13) PMID: 36034841; PMCID: PMC9399808.CrossRef Veiga ECA, Korkes HA, Salomão KB, Cavalli RC. Association of LEPTIN and other inflammatory markers with preeclampsia: a systematic review. Front Pharmacol. 2022;10(13) PMID: 36034841; PMCID: PMC9399808.CrossRef
40.
Zurück zum Zitat • Abraham T, Romani AMP. The relationship between obesity and pre-eclampsia: incidental risks and identification of potential biomarkers for pre-eclampsia. Cells. 2022;11(9):1548. https://doi.org/10.3390/cells11091548. This review provides confirmation of obesity as a significant risk factor for PE, emphasizing the potential role of dysmetabolic conditions and abnormal adipokine levels in the pathophysiological processes and as potential markers of PE.CrossRefPubMedPubMedCentral • Abraham T, Romani AMP. The relationship between obesity and pre-eclampsia: incidental risks and identification of potential biomarkers for pre-eclampsia. Cells. 2022;11(9):1548. https://​doi.​org/​10.​3390/​cells11091548. This review provides confirmation of obesity as a significant risk factor for PE, emphasizing the potential role of dysmetabolic conditions and abnormal adipokine levels in the pathophysiological processes and as potential markers of PE.CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat • Syed H, Slayman T, DuChene Thoma K. ACOG Committee Opinion No. 804: physical activity and exercise during pregnancy and the postpartum period. Obstet Gynecol. 2021;137(2):375–6. https://doi.org/10.1097/AOG.0000000000004266. PMID: 33481513. This comprehensive guideline statement, updates recent research findings on the advantages and potential risk of physical activity and exercise during pregnancy and the postpartum period.CrossRefPubMed • Syed H, Slayman T, DuChene Thoma K. ACOG Committee Opinion No. 804: physical activity and exercise during pregnancy and the postpartum period. Obstet Gynecol. 2021;137(2):375–6. https://​doi.​org/​10.​1097/​AOG.​0000000000004266​. PMID: 33481513. This comprehensive guideline statement, updates recent research findings on the advantages and potential risk of physical activity and exercise during pregnancy and the postpartum period.CrossRefPubMed
49.
Zurück zum Zitat • Perry A, Stephanou A, Rayman MP. Dietary factors that affect the risk of pre-eclampsia. BMJ Nutr Prev Health. 2022;5(1):118–33. https://doi.org/10.1136/bmjnph-2021-000399. PMID: 35814725; PMCID: PMC9237898. This very useful e review provides recommendations on reducing this risk by emphasizing the significance of dietary choices and maternal weight management, especially for individuals at a higher risk.CrossRefPubMedPubMedCentral • Perry A, Stephanou A, Rayman MP. Dietary factors that affect the risk of pre-eclampsia. BMJ Nutr Prev Health. 2022;5(1):118–33. https://​doi.​org/​10.​1136/​bmjnph-2021-000399. PMID: 35814725; PMCID: PMC9237898. This very useful e review provides recommendations on reducing this risk by emphasizing the significance of dietary choices and maternal weight management, especially for individuals at a higher risk.CrossRefPubMedPubMedCentral
Metadaten
Titel
The Role of Obesity in the Development of Preeclampsia
verfasst von
Miguel Javier Schiavone
Mariana Paula Pérez
Analía Aquieri
Daniela Nosetto
María Victoria Pronotti
María Mazzei
Cyntia Kudrle
Horacio Avaca
Publikationsdatum
21.03.2024
Verlag
Springer US
Erschienen in
Current Hypertension Reports
Print ISSN: 1522-6417
Elektronische ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-024-01299-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.